BIOMAT Database Logo BIOMAT Database Logo

Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67. 1994

N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Department of Neurosurgery, University of Mainz, Germany.

Obtaining growth fractions from immunohistological preparations by the commonly used cell count calculation method is time consuming. For the first time, we investigated and compared the detection of proliferating cells in immunohistologically labeled tissue from tumors of the nervous system using the monoclonal antibody Ki-67 by a new computerized image analysis system and by cell count calculation. The two methods showed a high correlation (correlation index, 0.98) in 37 gliomas (2 pilocytic astrocytomas, 10 Grade II astrocytomas, 5 Grade III astrocytomas, 20 Grade IV astrocytomas and glioblastoma multiforme) and a heterogenous group of 10 additional tumors of the nervous system, including oligodendroglioma, pineoblastoma, primary central nervous system lymphoma, and neurofibroma. Advantages of and indications for image analysis are as follows: 1) time-saving evaluation of immunohistological preparations enables their use in neuro-oncological routine diagnostics and examination of larger cell populations, thus leading to more precisely reproducible results, especially in heterogenous tumors; 2) image analysis, calculating the area of cell nuclei rather than their number, avoids difficulties with fragmented or overlapping nuclei; 3) analysis of different antibodies (for example, Ki-67 and anti-proliferating cell nuclear antigen) may be performed with the same program; 4) investigation of a larger patient group may lead, in combination with the histopathological diagnosis and clinical parameters, to better adapted therapeutic concepts.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females

Related Publications

N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Immunohistological detection of proliferating cells in normal and psoriatic epidermis using Ki-67 monoclonal antibody.
November 1990, Journal of dermatological science,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
[The identification of proliferating cells in nervous system neoplasms by use of the monoclonal antibody Ki-67].
December 1987, Neurologia medico-chirurgica,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
February 1988, Neurosurgery,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
January 1994, Acta neuropathologica,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Identification of proliferating cells by Ki-67 antibody.
January 1990, Methods in cell biology,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67.
January 1994, Gynecologic and obstetric investigation,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Ki-67 monoclonal antibody.
January 1991, British journal of neurosurgery,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Improved grading of bone tumors with the monoclonal antibody Ki-67.
January 1986, Journal of cancer research and clinical oncology,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
January 1991, Oncology,
N J Hopf, and J Bremm, and J Bohl, and A Perneczky
Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.
January 1987, Acta neuropathologica,
Copied contents to your clipboard!